A third systematic review concluded ADHD medication reduced symptoms and impairments but found limited and inconsistent evidence for long-term medication effects on social functioning, academic achievement, employment status, and psychiatric comorbidity¶

Claim · All claims
Evidence · 1 study · review r2 · q2
Currency · newest study 2018 · not yet checked against its sources · not reviewed by a person

Subclaims¶

q2 i? A systematic review of placebo-controlled discontinuation studies and prospective long-term observational studies concluded that ADHD medication reduced ADHD symptoms and impairments, but there was limited and inconsistent evidence for long-term medication effects on improved social functioning, academic achievement, employment status, and psychiatric comorbidity. → Franke 2018

Evidence¶

Franke 2018¶

Franke, B.; Michelini, G.; Asherson, P.; Banaschewski, T.; Bilbow, A.; Buitelaar, J.K.; Cormand, B.; Faraone, S.V; Ginsberg, Y.; Haavik, J.; Kuntsi, J.; Larsson, H.; Lesch, K.P.; Ramos-Quiroga, J.A.; Réthelyi, J.M.; Ribases, M.; Reif, A. (2018). Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan. European Neuropsychopharmacology. https://doi.org/10.1016/j.euroneuro.2018.08.001

q2 · i? · review · r2

Narrative review of disease outcome with and without treatment, reporting a systematic review attributed to van de Loo-Neus et al. (2011). The review states ADHD medication "reduced ADHD symp- toms and impairments" but evidence for long-term functional effects was "limited and in- consistent". No effect sizes printed.

"In contrast, a third systematic review of placebo-controlled discontinua- tion studies and prospective long-term observational stud- ies concluded that ADHD medication reduced ADHD symp- toms and impairments, but that there was limited and in- consistent evidence for long-term medication effects on im- proved social functioning, academic achievement, employ- ment status, and psychiatric comorbidity ( van de Loo-Neus et al., 2011 )."

Discussion¶

Related Claims¶

• Medication use does not affect creativity measures in adults with ADHD — related
• At least 15% of children with ADHD continue to meet full diagnostic criteria by age 25 and a further 50% meet criteria in partial remission, with European estimates of persistence up to 80%
• ADHD is associated with poor academic outcomes, including lower grade point average, increased grade retention, and lower rates of high-school graduation and post-secondary education
• Non-pharmacological treatments in childhood show lesser efficacy than ADHD drugs on core symptoms; only free fatty acid supplementation and exclusion of artificial food colour reached significance, with relatively small effects
• A large Swedish register-based study found treatment with ADHD medication significantly reduces the risk for criminality in adults with ADHD — related
• Pharmaco-epidemiological register studies indicate ADHD medication treatment reduces risk of injuries and emergency ward visits in children with ADHD — related